Pituitary actions of RFamide peptides: A critique of the evidence

Open Neuroendocrinology Journal

Volumn 4, Issue SPEC. ISSUE 1, 2011, Pages 51-63

  Anderson, Greg M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

26RFa; GnIH; Kisspeptin; NPAF; NPFF; Pituitary; PrRP; QRFP; RFamide; RFRP

Indexed keywords

ARGINYLPHENYLALANINAMIDE PEPTIDE; ARGINYLPHENYLALANINAMIDE PEPTIDE 43; ARGINYLPHENYLALANINAMIDE RELATED PEPTIDE 1; ARGINYLPHENYLALANINAMIDE RELATED PEPTIDE 3; KISSPEPTIN; NEUROPEPTIDE; NEUROPEPTIDE AF; NEUROPEPTIDE FF; OCTAPEPTIDE; PROLACTIN RELEASING FACTOR; UNCLASSIFIED DRUG;

ARGINYLPHENYLALANINAMIDE PEPTIDE GENE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN REGION; GENE; HUMAN; HYPOPHYSIS CELL; HYPOPHYSIS FUNCTION; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NOMENCLATURE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

EID: 80455145261     PISSN: None     EISSN: 18765289     Source Type: Journal    
DOI: 10.2174/1876528901104010051     Document Type: Article

References (173)

1. Price DA, Greenberg MJ. Structure of a molluscan cardioexcitatory neuropeptide. Science 1977; 197: 670-671.
2. Yang HY, Fratta W, Majane EA, Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A 1985; 82: 7757-7761.
3. Bechtold DA, Luckman SM. The role of RFamide peptides in feeding. J Endocrinol 2007; 192: 3-15.
4. Osugi T, Ukena K, Sower SA, Kawauchi H, Tsutsui K. Evolutionary origin and divergence of PQRFamide peptides and LPXRFamide peptides in the RFamide peptide family. Insights from novel lamprey RFamide peptides. FEBS J 2006; 273: 1731-1743.
5. Dockray GJ. The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp Physiol 2004; 89: 229-235.
6. Yoshida H, Habata Y, Hosoya M, Kawamata Y, Kitada C, Hinuma S. Molecular properties of endogenous RFamide-related peptide-3 and its interaction with receptors. Biochim Biophys Acta 2003; 1593: 151-157.
7. Engstrom M, Brandt A, Wurster S, Savola JM, Panula P. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J Pharmacol Exp Ther 2003; 305: 825-832.
8. Bonini JA, Jones KA, Adham N, et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 2000; 275: 39324-39331.
9. Hinuma S, Shintani Y, Fukusumi S, et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2000; 2: 703-708.
10. Quennell JH, Rizwan MZ, Relf HL, Anderson GM. Developmental and steroidogenic effects on the gene expression of RFRP and its receptor in the rat brain and pituitary gland. J Neuroendocrinol 2010; 22: 309-316.
11. Nieminen ML, Brandt A, Pietila P, Panula P. Expression of mammalian RF-amide peptides neuropeptide FF (NPFF), prolactinreleasing peptide (PrRP) and the PrRP receptor in the peripheral tissues of the rat. Peptides 2000; 21: 1695-1701.
12. Fujii R, Fukusumi S, Hosoya M, et al. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul Pept 1999; 83: 1-10.
13. Roland BL, Sutton SW, Wilson SJ, et al. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology 1999; 140: 5736-5757.
14. Jarry H, Heuer H, Schomburg L, Bauer K. Prolactin-releasing peptides do not stimulate prolactin release in vivo. Neuroendocrinology 2000; 71: 262-226
15. Fukusumi S, Yoshida H, Fujii R, et al. A new peptidic ligand and ts receptor regulating adrenal function in rats. J Biol Chem 2003; 278: 46387-46395.
16. Anko ML, Panula P. Functional modulation of human delta opioid receptor by neuropeptide FF. BMC Neurosci 2005; 6: 21.
17. Li MD, McAllen K, Sharp BM. Regulation of delta opioid receptor expression by anti-CD3-epsilon, PMA, and ionomycin in murine splenocytes and T cells. J Leukoc Biol 1999; 65: 707-714.
18. Smith JT, Rao A, Pereira A, Caraty A, Millar RP, Clarke IJ. Kisspeptin is present in ovine hypophysial portal blood, but does not increase during the preovulatory luteinizing hormone surge: Evidence that gonadotropes are not direct targets of kisspeptin in vivo. Endocrinology 2008; 149: 1951-1959.
19. Aarnisalo AA, Karhunen T, Vanhatalo S, Panula P. Peptide GEGLSS-like immunoreactivity in the rat central nervous system. Brain Res Bull 1997; 44: 91-96.
20. Morales T, Hinuma S, Sawchenko PE. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurones. J Neuroendocrinol 2000; 12: 131-140.
21. Rizwan MZ, Porteous R, Herbison AE, Anderson GM. Cells expressing RFamide-related peptide-1/3, the mammalian gonadotropin- inhibitory hormone orthologs, are not hypophysiotropic neuroendocrine neurons in the rat. Endocrinology 2009; 150: 1413-1420.
22. Perry SJ, Yi-Kung Huang E, Cronk D, et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 1997; 409: 426-430.
23. Vilim FS, Aarnisalo AA, Nieminen ML, et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 1999; 55: 804-811.
24. Elshourbagy NA, Ames RS, Fitzgerald LR, et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G proteincoupled receptor. J Biol Chem 2000; 275: 25965-25971.
25. Kotani M, Mollereau C, Detheux M, et al. Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 2001; 133: 138-144.
26. Mollereau C, Mazarguil H, Marcus D, et al. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol 2002; 451: 245-256.
27. Liu Q, Guan XM, Martin WJ, et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 2001; 276: 36961-36969.
28. Kavaliers M, Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Peptides 1992; 13: 603-607.
29. Gelot A, Frances B, Roussin A, Latapie JP, Zajac JM. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice. Brain Res 1998; 808: 166-173.
30. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A, Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res 1999; 848: 191-19
31. Tan PP, Chen JC, Li JY, Liang KW, Wong CH, Huang EY. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides 1999; 20: 1211-1217.
32. Gouarderes C, Jhamandas K, Sutak M, Zajac JM. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br J Pharmacol 1996; 117: 493-501.
33. Malin DH, Lake JR, Fowler DE, et al. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 1990; 11: 277-280.
34. Malin DH, Lake JR, Leyva JE, et al. Analog of neuropeptide FF attenuates morphine abstinence syndrome. Peptides 1991; 12: 1011-1014.
35. Murase T, Arima H, Kondo K, Oiso Y. Neuropeptide FF reduces food intake in rats. Peptides 1996; 17: 353-354.
36. Nicklous DM, Simansky KJ. Neuropeptide FF exerts pro- and antiopioid actions in the parabrachial nucleus to modulate food intake. Am J Physiol Regul Integr Comp Physiol 2003; 285: R1046-R1054.
37. Jaszberenyi M, Bagosi Z, Thurzo B, Foldesi I, Szabo G, Telegdy G. Endocrine, behavioral and autonomic effects of neuropeptide AF. Horm Behav 2009; 56: 24-34.
38. Gibson EM, Humber SA, Jain S, et al. Alterations in RFamiderelated peptide expression are coordinated with the preovulatory luteinizing hormone surge. Endocrinology 2008; 149: 4958-4969.
39. Ubuka T, Morgan K, Pawson AJ, et al. Identification of human GnIH homologs, RFRP-1 and RFRP-3, and the cognate receptor, GPR147 in the human hypothalamic pituitary axis. PLoS One 2009; 4: e8400.
40. Nieminen ML, Nystedt J, Panula P. Expression of neuropeptide FF, prolactin-releasing peptide, and the receptor UHR1/GPR10 genes during embryogenesis in the rat. Dev Dyn 2003; 226: 561-569.
41. Majane EA, Panula P, Yang HY. Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide. Brain Res 1989; 494: 1-12.
42. Majane EA, Zhu J, Aarnisalo AA, Panula P, Yang HY. Origin of neurohypophyseal neuropeptide-FF (FLFQPQRF-NH2). Endocrinology 1993; 133: 1578-1584.
43. Kivipelto L. Ultrastructural localization of neuropeptide FF, a new neuropeptide in the brain and pituitary of rats. Regul Pept 1991; 34: 211-224.
44. Boersma CJ, Sonnemans MA, Van Leeuwen FW. Immunocytochemical localization of neuropeptide FF (FMRF amide-like peptide) in the hypothalamo-neurohypophyseal system of Wistar and Brattleboro rats by light and electron microscopy. J Comp Neurol 1993; 336: 555-570.
45. Majane EA, Yang HY. Mammalian FMRF-NH2-like peptide in rat pituitary: decrease by osmotic stimulus. Peptides 1991; 12: 1303-1308.
46. Panula P, Aarnisalo AA, Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 1996; 48: 461-487.
47. Goncharuk VD, Buijs RM, Mactavish D, Jhamandas JH. Neuropeptide FF distribution in the human and rat forebrain: a comparative immunohistochemical study. J Comp Neurol 2006; 496: 572-593.
48. Chartrel N, Dujardin C, Anouar Y, et al. Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc Natl Acad Sci U S A 2003; 100: 15247-15252.
49. Sundblom DM, Panula P, Fyhrquist F. Neuropeptide FF-like immunoreactivity in human plasma. Peptides 1995; 16: 347-350.
50. Sundblom DM, Hyrkko A, Fyhrquist F. Pulsatile secretion of neuropeptide FF into human blood. Peptides 1998; 19: 1165-1170.
51. Allard M, Labrouche S, Nosjean A, Laguzzi R. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J Pharmacol Exp Ther 1995; 274: 577-583.
52. Lefrere I, De Coppet P, Camelin JC, et al. Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness. J Biol Chem 2002; 277: 39169-39178.
53. Minault M, Lecron JC, Labrouche S, Simonnet G, Gombert J. Characterization of binding sites for neuropeptide FF on T lymphocytes of the Jurkat cell line. Peptides 1995; 16: 105-111.
54. Hinuma S, Habata Y, Fujii R, et al. A prolactin-releasing peptide in the brain. Nature 1998; 393: 272-276.
55. Hinuma S, Onda H, Fujino M. The quest for novel bioactive peptides utilizing orphan seven-transmembrane-domain receptors. J Mol Med 1999; 77: 495-504.
56. Zhang X, Danila DC, Katai M, Swearingen B, Klibanski A. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1999; 84: 4652-4655.
57. Lin SH, Leslie FM, Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res 2002; 952: 15-30.
58. Ibata Y, Iijima N, Kataoka Y, et al. Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain. Neurosci Res 2000; 38: 223-230.
59. Maruyama M, Matsumoto H, Fujiwara K, et al. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology 1999; 140: 2326-2333.
60. Maruyama M, Matsumoto H, Fujiwara K, et al. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 2001; 142: 2032-2038.
61. Matsumoto H, Maruyama M, Noguchi J, et al. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropinsecretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett 2000; 285: 234-238.
62. Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, Bloom SR. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology 2002; 76: 70-78.
63. Samson WK, Keown C, Samson CK, et al. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Endocrine 2003; 20: 59-66.
64. Maruyama M, Matsumoto H, Fujiwara K, et al. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci Lett 1999; 276: 193-196.
65. Iijima N, Matsumoto Y, Yano T, et al. A novel function of prolactin-releasing peptide in the control of growth hormone via secretion of somatostatin from the hypothalamus. Endocrinology 2001; 142: 3239-3243.
66. Seal LJ, Small CJ, Kim MS, et al. Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology 2000; 141: 1909-1912.
67. Hizume T, Watanobe H, Yoneda M, Suda T, Schioth HB. Involvement of prolactin-releasing peptide in the preovulatory luteinizing hormone and prolactin surges in the rat. Biochem Biophys Res Commun 2000; 279: 35-39.
68. Watanobe H. In vivo release of prolactin-releasing peptide in rat hypothalamus in association with luteinizing hormone and prolactin surges. Neuroendocrinology 2001; 74: 359-366.
69. Lawrence CB, Celsi F, Brennand J, Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci 2000; 3: 645-646.
70. Samson WK, Resch ZT, Murphy TC. A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation. Brain Res 2000; 858: 19-25.
71. Gu W, Geddes BJ, Zhang C, Foley KP, Stricker-Krongrad A. The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice. J Mol Neurosci 2004; 22: 93-103.
72. Bjursell M, Lenneras M, Goransson M, Elmgren A, Bohlooly YM. GPR10 deficiency in mice results in altered energy expenditure andobesity. Biochem Biophys Res Commun 2007; 363: 633-638.
73. Takayanagi Y, Matsumoto H, Nakata M, et al. Endogenous prolactin-releasing peptide regulates food intake in rodents. J Clin Invest 2008; 118: 4014-4024.
74. Samson WK, Resch ZT, Murphy TC, Chang JK. Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine 1998; 9: 289-291.
75. Kawamata Y, Fujii R, Fukusumi S, et al. Analyses for susceptibility of rat anterior pituitary cells to prolactin-releasing peptide. Endocrine 2000; 12: 215-221.
76. Christian HC, Chapman LP, Morris JF. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat. J Neuroendocrinol 2007; 19: 605-613.
77. Curlewis JD, Kusters DH, Barclay JL, Anderson ST. Prolactinreleasing peptide in the ewe: cDNA cloning, mRNA distribution and effects on prolactin secretion in vitro and in vivo. J Endocrinol 2002; 174: 45-53.
78. Rubinek T, Hadani M, Barkai G, Melmed S, Shimon I. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas. J Clin Endocrinol Metab 2001; 86: 2826-2830.
79. Spuch C, Diz-Chaves Y, Perez-Tilve D, Alvarez-Crespo M, Mallo F. Prolactin-releasing Peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo. Endocrine 2007; 31: 119-124.
80. Anderson ST, Kokay IC, Lang T, Grattan DR, Curlewis JD. Quantification of prolactin-releasing peptide (PrRP) mRNA expression in specific brain regions of the rat during the oestrous cycle and in lactation. Brain Res 2003; 973: 64-73.
81. Matsumoto H, Noguchi J, Horikoshi Y, et al. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun 1999; 259: 321-324.
82. Tokita R, Nakata T, Katsumata H, et al. Prolactin secretion in response to prolactin-releasing peptide and the expression of the prolactin-releasing peptide gene in the medulla oblongata are estrogen dependent in rats. Neurosci Lett 1999; 276: 103-106.
83. Yamakawa K, Kudo K, Kanba S, Arita J. Distribution of prolactinreleasing peptide-immunoreactive neurons in the rat hypothalamus. Neurosci Lett 1999; 267: 113-116
84. Moriyama S, Ito T, Takahashi A, et al. A homolog of mammalian PRL-releasing peptide (fish arginyl-phenylalanyl-amide peptide) is a major hypothalamic peptide of PRL release in teleost fish. Endocrinology 2002; 143: 2071-2079
85. Kwong AK, Woo NY. Prolactin-releasing peptide, a possible modulator of prolactin in the euryhaline silver sea bream (Sparus sarba): A molecular study. Gen Comp Endocrinol 2008; 158: 154-160.
86. Matsumoto H, Murakami Y, Horikoshi Y, et al. Distribution and characterization of immunoreactive prolactin-releasing peptide (PrRP) in rat tissue and plasma. Biochem Biophys Res Commun 1999; 257: 264-268.
87. Fukusumi S, Habata Y, Yoshida H, et al. Characteristics and distribution of endogenous RFamide-related peptide-1. Biochim Biophys Acta 2001; 1540: 221-232.
88. Ukena K, Iwakoshi E, Minakata H, Tsutsui K. A novel rat hypothalamic RFamide-related peptide identified by immunoaffinity chromatography and mass spectrometry. FEBS Lett 2002; 512: 255-258.
89. Ducret E, Anderson GM, Herbison AE. RFamide-related peptide-3, a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone neuron firing in the mouse. Endocrinology 2009; 150: 2799-2804.
90. Wu M, Dumalska I, Morozova E, van den Pol AN, Alreja M. Gonadotropin inhibitory hormone inhibits basal forebrain vGluT2- gonadotropin-releasing hormone neurons via a direct postsynaptic mechanism. J Physiol 2009; 587: 1401-1411.
91. Johnson MA, Tsutsui K, Fraley GS. Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat. Horm Behav 2007; 51: 171-180.
92. Kriegsfeld LJ, Mei DF, Bentley GE, et al. Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals. Proc Natl Acad Sci U S A 2006; 103: 2410-2415.
93. Smith JT, Coolen LM, Kriegsfeld LJ, et al. Variation in kisspeptin and gonadotropin-inhibitory hormone expression and terminal connections to GnRH neurons in the brain: a novel medium for seasonal breeding in the sheep. Endocrinology 2008; 149: 5770-5782.
94. Ubuka T, Lai H, Kitani M, et al. Gonadotropin-inhibitory hormone identification, cDNA cloning, and distribution in rhesus macaque brain. J Comp Neurol 2009; 517: 841-855.
95. Anderson GM, Relf HL, Rizwan MZ, Evans JJ. Central and peripheral effects of RFamide-related peptide-3 on luteinizing hormone and prolactin secretion in rats. Endocrinology 2009; 150: 1834-1840.
96. Paul MJ, Pyter LM, Freeman DA, Galang J, Prendergast BJ. Photic and nonphotic seasonal cues differentially engage hypothalamic kisspeptin and RFamide-related peptide mRNA expression in Siberian hamsters. J Neuroendocrinol 2009; 21: 1007-1014.
97. Revel FG, Saboureau M, Pevet P, Simonneaux V, Mikkelsen JD. RFamide-related peptide gene is a melatonin-driven photoperiodic gene. Endocrinology 2008; 149: 902-912.
98. Dardente H, Birnie M, Lincoln GA, Hazlerigg DG. RFamiderelated peptide and its cognate receptor in the sheep: cDNA cloning, mRNA distribution in the hypothalamus and the effect of photoperiod. J Neuroendocrinol 2008; 20: 1252-1259.
99. Kirby ED, Geraghty AC, Ubuka T, Bentley GE, Kaufer D. Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats. Proc Natl Acad Sci U S A 2009; 106: 11324-11329.
100. Murakami M, Matsuzaki T, Iwasa T, et al. Hypophysiotropic role of RFamide-related peptide-3 (RFRP-3) in the inhibition of LH secretion in female rats. J Endocrinol 2008; 199: 105-112.
101. Johnson MA, Fraley GS. Rat RFRP-3 alters hypothalamic GHRH expression and growth hormone secretion but does not affect KiSS- 1 gene expression or the onset of puberty in male rats. Neuroendocrinology 2008; 88: 305-315.
102. Pineda R, Garcia-Galiano D, Sanchez-Garrido MA, et al. Characterization of inhibitory roles of RFRP3, the mammalian ortholog of GnIH, in the control of gonadotropin secretion in the rat: In vivo and in vitro studies. Am J Physiol Endocrinol Metab 2010; In press.
103. Yano T, Iijima N, Kakihara K, Hinuma S, Tanaka M, Ibata Y. Localization and neuronal response of RFamide related peptides in the rat central nervous system. Brain Res 2003; 982: 156-167.
104. Kaewwongse M, Takayanagi Y, Onaka T. Effects of RFRP-1 and RFRP-3 on oxytocin release and anxiety-related behaviour in rats. J Neuroendocrinol 2010; 23(1): 20-27.
105. Clarke IJ, Sari IP, Qi Y, et al. Potent action of RFRP-3 on pituitary gonadotropes indicative of an hypophysiotropic role in the negative regulation of gonadotropin secretion. Endocrinology 2008; 149: 5811-5821.
106. Ukena K, Tsutsui K. Distribution of novel RFamide-related peptide-like immunoreactivity in the mouse central nervous system. Neurosci Lett 2001; 300: 153-156.
107. Smith JT, Shahab M, Pereira A, Pau KY, Clarke IJ. Hypothalamic expression of KISS1 and gonadotropin inhibitory hormone genes during the menstrual cycle of a non-human primate. Biol Reprod 2010; In press.
108. Tsutsui K, Saigoh E, Ukena K, et al. A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochem Biophys Res Commun 2000; 275: 661-667.
109. Ubuka T, Ueno M, Ukena K, Tsutsui K. Developmental changes in gonadotropin-inhibitory hormone in the Japanese quail (Coturnix japonica) hypothalamo-hypophysial system. J Endocrinol 2003; 178: 311-318.
110. Ukena K, Ubuka T, Tsutsui K. Distribution of a novel avian gonadotropin-inhibitory hormone in the quail brain. Cell Tissue Res 2003; 312: 73-77.
111. Osugi T, Ukena K, Bentley G, et al. Gonadotropin-inhibitory hormone in Gambel's white-crowned sparrow (Zonotrichia leucophrys gambelii): cDNA identification, transcript localization and functional effects in laboratory and field experiments. J Endocrinol 2004; 182: 33-42.
112. Ubuka T, Kim S, Huang YC, et al. Gonadotropin-inhibitory hormone neurons interact directly with gonadotropin-releasing hormone-I and -II neurons in European starling brain. Endocrinology 2008; 149: 268-278.
113. Kriegsfeld LJ. Driving reproduction: RFamide peptides behind the wheel. Horm Behav 2006; 50: 655-666.
114. Gross DS. Distribution of gonadotropin-releasing hormone in the mouse brain as revealed by immunohistochemistry. Endocrinology 1976; 98: 1408-1414.
115. Sari IP, Rao A, Smith JT, Tilbrook AJ, Clarke IJ. Effect of RFamide- related peptide-3 on luteinizing hormone and folliclestimulating hormone synthesis and secretion in ovine pituitary gonadotropes. Endocrinology 2009; 150: 5549-5555.
116. Kadokawa H, Shibata M, Tanaka Y, et al. Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines. Domest Anim Endocrinol 2009; 36: 219-224.
117. Simonin F, Schmitt M, Laulin JP, et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA 2006; 103: 466-471.
118. Pineda R, Garcia-Galiano D, Sanchez-Garrido MA, et al. Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications. Endocrinology 2010; 151: 1902-1913.
119. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001; 276: 34631-34636.
120. Muir AI, Chamberlain L, Elshourbagy NA, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001; 276: 28969-28975.
121. Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411: 613-617.
122. Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996; 88: 1731-1737.
123. Lee DK, Nguyen T, O'Neill GP, et al. Discovery of a receptor related to the galanin receptors. FEBS Lett 1999; 446: 103-107.
124. Clements MK, McDonald TP, Wang R, et al. FMRFamide-related neuropeptides are agonists of the orphan G-protein-coupled receptor GPR54. Biochem Biophys Res Commun 2001; 284: 1189-1193.
125. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004; 117: 1319-1328.
126. Mikkelsen JD, Bentsen AH, Ansel L, Simonneaux V, Juul A. Comparison of the effects of peripherally administered kisspeptins. Regul Pept 2009; 152: 95-100.
127. Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 2007; 151: 1143-1153.
128. Gottsch ML, Cunningham MJ, Smith JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004; 145: 4073-4077.
129. Han SK, Gottsch ML, Lee KJ, et al. Activation of gonadotropinreleasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci 2005; 25: 11349-11356.
130. Liu X, Lee K, Herbison AE. Kisspeptin excites gonadotropinreleasing hormone neurons through a phospholipase C/calciumdependent pathway regulating multiple ion channels. Endocrinology 2008; 149: 4605-4614.
131. Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun 2004; 320: 383-388.
132. Clarkson J, Han SK, Liu X, Lee K, Herbison AE. Neurobiological mechanisms underlying kisspeptin activation of gonadotropinreleasing hormone (GnRH) neurons at puberty. Mol Cell Endocrinol 2010.
133. Clarkson J, Herbison AE. Oestrogen, kisspeptin, GPR54 and the pre-ovulatory luteinising hormone surge. J Neuroendocrinol 2009; 21: 305-311.
134. Tena-Sempere M. Kisspeptins and the metabolic control of reproduction: Physiologic roles and physiopathological implications. Ann Endocrinol Paris 2010; 71(3): 201-202.
135. Clarke IJ, Smith JT, Caraty A, Goodman RL, Lehman MN. Kisspeptin and seasonality in sheep. Peptides 2009; 30: 154-163.
136. Simonneaux V, Ansel L, Revel FG, Klosen P, Pevet P, Mikkelsen JD. Kisspeptin and the seasonal control of reproduction in hamsters. Peptides 2009; 30: 146-153.
137. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003; 349: 1614-1627.
138. Clarkson J, d'Anglemont de Tassigny X, Moreno AS, Colledge WH, Herbison AE. Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge. J Neurosci 2008; 28: 8691-8697.
139. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A 2003; 100: 10972-10976.
140. Semple RK, Achermann JC, Ellery J, et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90: 1849-1855.
141. Szawka RE, Ribeiro AB, Leite CM, et al. Kisspeptin regulates prolactin release through hypothalamic dopaminergic neurons. Endocrinology 2010; 151(7): 3247-3257.
142. Hiden U, Bilban M, Knofler M, Desoye G. Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 2007; 8: 31-39.
143. Richard N, Corvaisier S, Camacho E, Kottler ML. KiSS-1 and GPR54 at the pituitary level: overview and recent insights. Peptides 2009; 30: 123-129.
144. Richard N, Galmiche G, Corvaisier S, Caraty A, Kottler ML. KiSS- 1 and GPR54 genes are co-expressed in rat gonadotrophs and differentially regulated in vivo by oestradiol and gonadotrophinreleasing hormone. J Neuroendocrinol 2008; 20: 381-393.
145. Gutierrez-Pascual E, Martinez-Fuentes AJ, Pinilla L, Tena-Sempere M, Malagon MM, Castano JP. Direct pituitary effects of kisspeptin: activation of gonadotrophs and somatotrophs and stimulation of luteinising hormone and growth hormone secretion. J Neuroendocrinol 2007; 19: 521-530.
146. Navarro VM, Castellano JM, Fernandez-Fernandez R, et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on folliclestimulating hormone secretion in the rat. Endocrinology 2005; 146: 1689-1697.
147. Thompson EL, Patterson M, Murphy KG, et al. Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol 2004; 16: 850-858.
148. Suzuki S, Kadokawa H, Hashizume T. Direct kisspeptin-10 stimulation on luteinizing hormone secretion from bovine and porcine anterior pituitary cells. Anim Reprod Sci 2008; 103: 360-365.
149. Kadokawa H, Suzuki S, Hashizume T. Kisspeptin-10 stimulates the secretion of growth hormone and prolactin directly from cultured bovine anterior pituitary cells. Anim Reprod Sci 2008; 105: 404-408.
150. Clarkson J, Herbison AE. Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. Endocrinology 2006; 147: 5817-5825.
151. Brailoiu GC, Dun SL, Ohsawa M, et al. KiSS-1 expression and metastin-like immunoreactivity in the rat brain. J Comp Neurol 2005; 481: 314-329.
152. Mikkelsen JD, Simonneaux V. The neuroanatomy of the kisspeptin system in the mammalian brain. Peptides 2009; 30: 26-33.
153. Ramaswamy S, Guerriero KA, Gibbs RB, Plant TM. Structural interactions between kisspeptin and GnRH neurons in the mediobasal hypothalamus of the male rhesus monkey (Macaca mulatta) as revealed by double immunofluorescence and confocal microscopy. Endocrinology 2008; 149: 4387-4395.
154. Keen KL, Wegner FH, Bloom SR, Ghatei MA, Terasawa E. An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalkmedian eminence of female rhesus monkeys in vivo. Endocrinology 2008; 149: 4151-4157.
155. Franceschini I, Lomet D, Cateau M, Delsol G, Tillet Y, Caraty A. Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci Lett 2006; 401: 225-230.
156. Yang B, Jiang Q, Chan T, Ko WK, Wong AO. Goldfish kisspeptin: molecular cloning, tissue distribution of transcript expression, and stimulatory effects on prolactin, growth hormone and luteinizing hormone secretion and gene expression via direct actions at the pituitary level. Gen Comp Endocrinol 2010; 165: 60-71.
157. Ramaswamy S, Gibbs RB, Plant TM. Studies of the localisation of kisspeptin within the pituitary of the rhesus monkey (Macaca mulatta) and the effect of kisspeptin on the release of nongonadotropic pituitary hormones. J Neuroendocrinol 2009; 21: 795-804.
158. Plant TM, Ramaswamy S, Dipietro MJ. Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 2006; 147: 1007-1013.
159. Roa J, Castellano JM, Navarro VM, Handelsman DJ, Pinilla L, Tena-Sempere M. Kisspeptins and the control of gonadotropin secretion in male and female rodents. Peptides 2009; 30: 57-66.
160. Jiang Y, Luo L, Gustafson EL, et al. Identification and characterization of a novel RF-amide peptide ligand for orphan Gprotein- coupled receptor SP9155. J Biol Chem 2003; 278: 27652-27657.
161. Takayasu S, Sakurai T, Iwasaki S, et al. A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice. Proc Natl Acad Sci U S A 2006; 103: 7438-7443.
162. Bruzzone F, Lectez B, Tollemer H, et al. Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord. J Neurochem 2006; 99: 616-627.
163. Fukusumi S, Fujii R, Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 2006; 27: 1073-1086.
164. Lee DK, Nguyen T, Lynch KR, et al. Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 2001; 275: 83-91.
165. Bruzzone F, Lectez B, Alexandre D, et al. Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. J Comp Neurol 2007; 503: 573-591.
166. Kampe J, Wiedmer P, Pfluger PT, et al. Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat. Brain Res 2006; 1119: 133-149.
167. Patel SR, Murphy KG, Thompson EL, et al. Pyroglutamylated RFamide peptide 43 stimulates the hypothalamic-pituitary-gonadal axis via gonadotropin-releasing hormone in rats. Endocrinology 2008; 149: 4747-4754.
168. Navarro VM, Fernandez-Fernandez R, Nogueiras R, et al. Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axis. J Physiol 2006; 573: 237-249.
169. Yamamoto T, Miyazaki R, Yamada T. Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test. Peptides 2009; 30: 1683-1688.
170. Yamamoto T, Wada T, Miyazaki R. Analgesic effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats. Neuroscience 2008; 157: 214-222.
171. Primeaux SD, Blackmon C, Barnes MJ, Braymer HD, Bray GA. Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats. Peptides 2008; 29: 1994-2000.
172. do Rego JC, Leprince J, Chartrel N, Vaudry H, Costentin J. Behavioral effects of 26RFamide and related peptides. Peptides 2006; 27: 2715-2721.
173. Clarke I, Jessop D, Millar R, et al. Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep. Neuroendocrinology 1993; 57: 765-775.